Evaluation of folate conjugate uptake and transport by the choroid plexus of mice

Pharmaceutical Research

Volumn 20, Issue 5, 2003, Pages 714-719

  Kennedy, Michael D ^a   Jallad, Karim N ^a   Lu, June ^b   Low, Philip S ^a   Ben Amotz, Dor ^a  

^a PURDUE UNIVERSITY   (United States)

^b Endocyte Inc   (United States)

Author keywords

Blood CSF barrier; Choroid plexus; Fluorescein; Folate receptor; Folic acid

Indexed keywords

FLUORESCEIN; FOLATE RECEPTOR; FOLIC ACID DERIVATIVE; INDIUM 111; IODINE; PENTETIC ACID; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CHOROID PLEXUS; CONJUGATE; DRUG TRANSPORT; DRUG UPTAKE; FLUORESCENCE; IMAGE ANALYSIS; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; CHEMISTRY, PHARMACEUTICAL; CHOROID PLEXUS; DRUG EVALUATION, PRECLINICAL; FOLIC ACID; MICE; MICE, INBRED BALB C; PENTETIC ACID;

EID: 0037407674     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023421232689     Document Type: Article

References (25)

1. F. M. Sirotnak and B. Tolner. Carrier-mediated membrane transport of folates in mammalian cells. Annu. Rev. Nutr. 19:91-122 (1999).
2. X. Wang, F. Shen, J. H. Freisheim, L. E. Gentry, and M. Ratnam. Differential stereospecificities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem. Pharmacol. 44:1898-1901 (1992).
3. J. J. Turek, C. P. Leamon, and P. S. Low. Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. J. Cell Sci. 106:423-430 (1993).
4. J. Selhub, D. Emmanouel, T. Stavropoulos, and R. Arnold. Renal folate absorption and the kidney folate binding protein. I. Urinary clearance studies. Am. J. Physiol. 252:F750-F756 (1987).
5. J. T. Hjelle, E. I. Christensen, and F. A. Carone, and J. Selhub. Cell fractionation and electron microscope studies of kidney folate-binding protein. Am. J. Physiol. 260:C338-C346 (1991).
6. H. Birn, J. Selhub, and E. I. Christensen. Internalization and intracellular transport of folate-binding protein in rat kidney proximal tubule. Am. J. Physiol. 264:C302-C310 (1993).
7. A. C. Antony, C. Utley, K. C. Van Horne, and J. F. Kolhouse. Isolation and characterization of a folate receptor from human placenta. J. Biol. Chem. 256:9684-9692 (1981).
8. S. D. Weitman, R. H. Lark, L. R. Coney, D. W. Fort, V. Frasca, V. R. Zurawski Jr., and B. A. Kamen. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52:3396-3401 (1992).
9. W. J. Rettig, C. Cordon-Cardo, J. P. Koulos, J. L. Lewis, H. F. Oettgen, and L. J. Old. Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies. Int. J. Cancer 35:469-475 (1985).
10. S. Miotti, S. Canevari, S. Menard, D. Mezzanzanica, G. Porro, S. M. Pupa, M. Regazzoni, E. Tagliabue, and M. I. Colnaghi. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int. J. Cancer 39:297-303 (1987).
11. S. D. Weitman, K. M. Frazier, and B. A. Kamen. The folate receptor in central nervous system malignancies of childhood. J. Neurooncol. 21:107-112 (1994).
12. P. Garin-Chesa, J. Campbell, P. E. Saigo, J. L. Lewis Jr., L. J. Old, and W. J. Rettig. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol. 142:557-567 (1993).
13. W. A. Franklin, M. Waintrub, D. Edwards, K. Christensen, P. Prendegrast, J. Woods, P. A. Bunn, and J. F. Kolhouse. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma. Int. J. Cancer Suppl. 8:89-95 (1994).
14. J. F. Ross, H. Wang, F. G. Behm, P. Mathew, M. Wu, R. Booth, and M. Ratnam. Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia. Cancer 85:348-357 (1999).
15. J. A. Reddy and P. S. Low. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit. Rev. Ther. Drug Carrier Syst. 15:587-627 (1998).
16. W. M. Williams and K. C. Huang. Renal tubular transport of folic acid and methotrexate. Am. J. Physiol. 11:F484-F490 (1982).
17. C. P. Chen and C. Wagner. Folate transport in the choroid plexus. Life Sci. 16:1571-1581 (1975).
18. R. Spector and A. V. Lorenzo. Folate transport by the choroid plexus in vitro. Science 187:540-542 (1975).
19. J. Luo, M. D. Smith, D. A. Lantrip, S. Wang, and P. L. Fuchs. Efficiant synthesis of pyrofolic acid and pteroyl A azide, reagents for the production of carboxyl differentiated derivatives of folic acid. J. Am. Chem. Soc. 119:10004-10013 (1997).
20. S. Wang, J. Luo, D. A. Lantrip, D. J. Waters, C. J. Mathias, M. A. Green, P. L. Fuchs, and P. S. Low. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjug. Chem. 8:673-679 (1997).
21. C. J. Mathias, S. Wang, D. J. Waters, J. J. Turek, P. S. Low, and M. A. Green. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J. Nucl. Med. 39:1579-1585 (1998).
22. T. A. Patrick, D. M. Kranz, T. A. van Dyke, and E. J. Roy. Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice. J. Neurooncol. 32:111-123 (1997).
23. D. Wu and W. M. Pardridge. Blood-brain barrier transport of reduced folic acid. Pharm. Res. 16:415-419 (1999).
24. N. Strazielle and J. F. Ghersi-Egea. Choroid plexus in the central nervous system: biology and physiopathology. J. of Neuropathol. Exp. Neurobiol. 59:561-574 (2000).
25. T. A. Patrick, D. M. Kranz, J. F. Zachary, and E. J. Roy. Intracerebral bispecific ligand-antibody conjugate increases survival of animals bearing endogenously arising brain tumors. Int. J. Cancer 78:470-479 (1998).